FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Global

  • Home
  •  | 
  • Tag Archives: "Global"

CANNMART RECEIVES CONFIRMATION FROM HEALTH CANADA THAT IT WILL BE ALLOWED TO PURCHASE PRE-PACKAGED, LABELLED AND TESTED CANNABIS PRODUCTS

CANNMART RECEIVES CONFIRMATION FROM HEALTH CANADA THAT IT WILL BE ALLOWED TO PURCHASE PRE-PACKAGED, LABELLED AND TESTED CANNABIS PRODUCTS
The update from Health Canada is a major milestone for Cannmart and the Canadian cannabis industry as a whole. In light of the upcoming regulation changes with the Cannabis Act, this amendment supports Licensed Producers, like Cannmart whose sole focus is on the sale and distribution of cannabis and cannabis products in Canada. Allowing Cannmart to purchase pre-packed products will not only eliminate the bottleneck at the Cannmart facility but more importantly, it will significantly reduce the costs associated with Cannmart and further support its business model. Most importantly, this decision will enable Cannmart to bring more value to patients in offering pre-packed, labelled products sourced directly from its Licensed Producer partners in a diverse online marketplace.
Read more

Chemesis International Inc. Announces Global Expansion Through Wholly Owned Subsidiary Chemesis Latin America

Chemesis International Inc. Announces Global Expansion Through Wholly Owned Subsidiary Chemesis Latin America
Sept. 11, 2018 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (the “Company” or “Chemesis”), a market leader in medicinal and recreational cannabis, is proud to announce the opening of its wholly owned subsidiary Chemesis Latin America. Through this subsidiary, the Company is exploring and completing advanced due diligence on opportunities for cultivation, production and export from the Latin American market. The Company believes it will be able to quickly gain market share in Latin America through the use of its networks and existing expertise.
Read more

Aphria and Rapid Dose Therapeutics Sign MOU to Bring Innovative QuickStrip™ Oral Thin Strips to Aphria’s Portfolio of Medical and Adult-Use Brands

Aphria and Rapid Dose Therapeutics Sign MOU to Bring Innovative QuickStrip™ Oral Thin Strips to Aphria’s Portfolio of Medical and Adult-Use Brands
Aphria Inc. ("Aphria" or the "Company") (TSX: APH andUS OTC: APHQF) and Rapid Dose Therapeutics Inc. ("RDT"), a Canadian bio-technology company focused on innovative drug delivery solutions, announced today that they have signed a non-binding Memorandum of Understanding ("MOU") related to RDT's QuickStrip™ products. Under the terms of the MOU, the companies intend to enter into a definitive agreement in the near future pursuant to which RDT will provide Aphria with exclusive global preferred rights to produce, distribute and sell QuickStrip™ products for cannabis markets around the world.
Read more